Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 104 | SFEIES24 | Next issue

Joint Irish-UK Endocrine Meeting 2024

Belfast, Northern Ireland
14 Oct 2024 - 15 Oct 2024

Card image cap

Oral Communications

Case Report Oral Communications

ea0104cr1 | Case Report Oral Communications | SFEIES24

Refractory hypercalcaemia in advanced metastatic pancreatic neuroendocrine tumour controlled on weekly denosumab

Wen Loh Ee , Masuka Shamiso , Wadsley Jonathan , Sabbagh Ahmad , Davies James , Newell-Price John

Background: Hypercalcaemia of malignancy (HCM) is the commonest metabolic complication of malignancies. However, this is relatively rare among patients with neuroendocrine tumors (NET). Management of HCM remains a challenge for clinicians, especially in cases of refractory hypercalcaemia.Case Report: A 37-year-old lady was referred to the NET service in June 2021 following the finding on imaging of a huge inoperable pancreatic mass with peritumoural vari...

ea0104cr2 | Case Report Oral Communications | SFEIES24

Use of radiofrequency ablation (RFA) in the management of thyroid nodules – a single centre experience

Ludgate Stephen , Dennehy Gina , McGowan Anne , Govender Pradeep , Gibney James

Radiofrequency ablation (RFA) is a minimally invasive technique using thermogenesis to induce tissue necrosis. Initially used to treat hepatocellular carcinoma, RFA is now used to treat numerous conditions including thyroid nodules. We present the use of RFA in 3 individuals with thyroid disease attending our centre. A 31-year-old female presented with symptoms of hyperthyroidism. Her TSH <0.02mIU/l (0.27-4.2), Free T4 (FT4) 20.2 pmol/l (11.9-21.6) and Free T3 (FT3) 8.5 pm...

ea0104cr3 | Case Report Oral Communications | SFEIES24

Adrenocorticotropin (ACTH) independent cushing’s syndrome in pregnancy secondary to overproduction of adrenal luteinizing hormone/human chorionic gonadotropins receptors

Jabeen Misbah , Yousaf Raja Umar , Satti Naila

We describe a case of a women with Cushing’s syndrome and bilateral adrenal nodules who presented with symptoms and signs of Cushing’s syndrome that manifested during pregnancy which unfortunately ended in a miscarriage in first trimester. Investigations showed raised urinary cortisols, failure of suppression of cortisol with dexamethasone and suppressed ACTH. CT adrenals showed bilateral macronodular adrenal hyperplasia. Patients’s history suggested she had sim...

ea0104cr4 | Case Report Oral Communications | SFEIES24

Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: a case study

Carthy Brian , Owens Lisa , Ann Behan Lucy , Tuthill Antoinette

We present a case of a thirty year old female with a history of primary amenorrhoea due to hypogonadotropic hypogonadism (HH) who was further investigated as family history revealed a brother and sister with normosmic hypogonadotropic hypogonadism due to a homozygous pathogenic variant c.1195T>A in the KISS1 receptor gene. Our patient carried the same homozygous mutation, and both parents (unrelated) were heterozygous carriers. KISS1-receptor mutations are a rare cause of ...

ea0104cr5 | Case Report Oral Communications | SFEIES24

Gastrointestinal morbidity related to delayed diagnosis of pheochromocytoma

Kaur Sehemby Manjeet , Buch Harit

Background: Although pheochromocytoma is feared for its acute life-threatening complications, in some patients the symptoms can be subtle. This leads to delayed diagnosis and chronic morbidity. We report 2 cases who presented with long history of major gastrointestinal manifestations related to a pheochromocytoma Case 1: A 51-year-old female had severe constipation for 12 years. No bowel pathology was identified on ultrasonography, colonoscopy, colonic transit studies and isot...

ea0104cr6 | Case Report Oral Communications | SFEIES24

GLP1 receptor agonist and sulphonylurea treatment in KCNJ11 permanent neonatal diabetes

Crowley Mairead , Roarty Sarah , O'Shea Helen , Hattersley Andrew , Byrne Maria

Heterozygous activating mutations of the KCNJ11 gene are the most common cause of permanent neonatal diabetes. High dose sulphonylurea (SU) therapy usually results in long-term glycaemic control. A 32-year-old woman presented at four weeks old with hyperglycaemia, ketonuria and acidosis. She was treated with insulin throughout childhood and adolescence. She was later diagnosed with a KCNJ11 mutation (R201H, c.601C>A). She successfully transitioned to SU o...